MARKET

IXHL

IXHL

Incannex Healthcare Ltd
NASDAQ
3.420
+0.220
+6.88%
After Hours: 3.440 +0.02 +0.58% 19:48 06/26 EDT
OPEN
3.160
PREV CLOSE
3.200
HIGH
3.470
LOW
3.160
VOLUME
227.28K
TURNOVER
--
52 WEEK HIGH
49.80
52 WEEK LOW
2.490
MARKET CAP
40.92M
P/E (TTM)
-0.2650
1D
5D
1M
3M
1Y
5Y
1D
Incannex granted IHL-42X composition patent by USPTO
TipRanks · 3d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 3d ago
Incannex Healthcare Secures U.S. Patent For Compositions And Methods Of Treatment For Obstructive Sleep Apnea
Benzinga · 3d ago
INCANNEX SECURES U.S. PATENT GRANT FOR IHL-42X IN OBSTRUCTIVE SLEEP APNEA
Reuters · 3d ago
Incannex Secures Key U.S. Patent for IHL-42X
TipRanks · 3d ago
INCANNEX HEALTHCARE - PATENT FOR IHL-42X EXPIRES JULY 9, 2040; EXTENSION POSSIBLE AFTER FDA APPROVAL - SEC FILING
Reuters · 3d ago
INCANNEX HEALTHCARE - GRANTED U.S. PATENT FOR IHL-42X IN OBSTRUCTIVE SLEEP APNOEA - SEC FILING
Reuters · 3d ago
Incannex wins US patent for IHL-42X obstructive sleep apnea therapy
PUBT · 3d ago
More
About IXHL
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.

Webull offers Incannex Healthcare Inc stock information, including NASDAQ: IXHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IXHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IXHL stock methods without spending real money on the virtual paper trading platform.